Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Biol Psychol. 2022 Feb 8;169:108286. doi: 10.1016/j.biopsycho.2022.108286

Table 1.

Sample Demographics and Clinical Characteristics

Group HC (n=41) MDD-SSRI (n=47) MDD-UnMed (n=48) p-value
Mean (sd) Mean (sd) Mean (sd) 3 groups MDD-Med vs. UnMed

Age 31.49 (10.54) 35.87 (11.21) 32.31 (11.28) .14a .13c
Body Mass Index 27.42 (5.16) 29.32 (5.39) 27.10 (5.60) .11a .06c
Sex = Male (%) 18 (43.9) 11 (23.4) 15 (31.2) .12b .53b
Education 6.39 (1.45) 6.72 (1.17) 6.12 (1.70) .14a .05c
Employed = Yes (%) 30 (76.9) 27 (58.7) 33 (71.7) .17b .27b
IPAQ minutes per week 4659.21 (3678.56) 3849.07 (4279.15) 3616.51 (4388.08) .51a .80c
IPAQ Category (%) .30b .81b
 HEPA Active 21 (58.3) 17 (37.8) 18 (40.9)
 Inactive 6 (16.7) 14 (31.1) 15 (34.1)
 Minimally Active 9 (25.0) 14 (31.1) 11 (25.0)
OASIS 1.12 (1.35) 10.32 (3.50) 9.29 (3.40) <.01a .15c
PHQ 0.78 (1.17) 14.52 (5.41) 14.88 (4.13) <.01a .72c
SCOFF 0.05 (0.22) 1.30 (1.27) 1.33 (1.29) <.01a .89c
DAST 0.07 (0.26) 0.51 (0.88) 0.50 (1.22) .04a .96c
PROMIS Alcohol Use Score 43.96 (6.86) 49.37 (5.92) 50.02 (7.36) <.01a .64c
PROMIS Nicotine Dependence Score 25.54 (7.36) 27.28 (10.54) 27.51 (10.39) .59a .91c
PROMIS Depression Score 42.95 (6.26) 63.07 (6.39) 63.63 (6.73) <.01a .68c
PROMIS Anxiety Score 45.50 (7.61) 63.93 (6.47) 63.34 (6.96) <.01a .67c
STAI Trait 27.71 (7.14) 55.96 (9.55) 57.85 (10.88) <.01a .36c
STAI State 26.10 (6.45) 47.62 (11.08) 50.42 (10.73) <.01a .21c
ASI Total Score 5.59 (6.99) 22.68 (14.20) 26.83 (15.31) <.01a .17c
MAIA Attention Regulation Score 3.54 (0.93) 2.88 (0.97) 2.81 (1.00) <.01a .73c
MAIA Body Listening Score 2.64 (1.39) 1.89 (1.17) 1.86 (1.36) <.01a .91c
MAIA Emotional Awareness Score 3.44 (1.07) 3.54 (1.08) 3.22 (1.22) .37a .18c
MAIA Not-Distracting Score 2.12 (1.08) 1.67 (0.90) 1.68 (0.88) <.05a .97c
MAIA Noticing Score 3.41 (1.08) 3.54 (1.09) 3.44 (1.20) .83a .64c
MAIA Not-Worrying Score 3.43 (0.98) 3.00 (0.83) 2.47 (1.20) <.01a .01c
MAIA Self-Regulation Score 3.59 (1.04) 2.57 (0.88) 2.12 (1.11) <.01a .03c
MAIA Trusting Score 3.95 (1.04) 2.71 (1.12) 2.45 (1.10) <.01a .25c
TAS-20 Difficulty Describing Feelings 12.29 (3.66) 15.09 (3.47) 15.96 (3.03) <.01a .20c
TAS-20 Difficulty Identifying Feelings 10.68 (4.27) 18.04 (6.20) 19.51 (6.38) <.01a .26c
TAS-20 Externally Oriented Thinking 26.10 (3.58) 26.02 (3.27) 25.43 (2.64) .54a .33c
TAS-20 Total Score 49.07 (8.89) 59.15 (9.15) 60.89 (9.02) <.01a .35c
RRS Score 28.65 (7.14) 56.94 (10.84) 58.54 (10.43) <.01a .46c
Current Depression = Yes (%) NA 47 (100.0) 48 (100.0) NA NA
Recurrent Depression = Yes (%) NA 45 (95.7) 36 (75.0) NA .04b
Comorbid Anxiety Disorder = Yes (%) NA 33 (70.2) 31 (64.6) NA .94b
Comorbid Alcohol Use Disorder = Yes (%) NA 4 (8.5) 8 (16.7) NA .33b
CDDR Lifetime Alcohol Use d 496.97 (1370.00) 623.98 (1397.15) 977.46 (4408.74.75) .70a .59c

Note. HC = healthy control. MDD = major depressive disorder. SSRI = Use of selective serotonin reuptake inhibitors. UnMed = unmedicated. IPAQ, International Physical Activity Questionnaire; OASIS, Overall Anxiety Severity and Impairment Scale; PHQ, Patient Health Questionnaire; SCOFF, Sick Control One Fat Food Questionnaire; DAST, Drug Use Questionnaire; PROMIS, Patient-Reported Outcomes Measurement Information System; STAI, State-Trait Anxiety Inventory; ASI, Anxiety Sensitivity Index; MAIA, Multidimensional Assessment of Interoceptive Awareness; TAS-20, Toronto Alexithymia Scale; RRS, Ruminative Responses Scale; CDDR, Customary Drinking And Drug Use Record.

a

One-way ANOVA test

b

X2 test.

c

Two Sample t-test.

d

One outlier from the MDD-SSRI group was excluded.